Science to transform lives

Immunocore is a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease

About us

Our science

We have a robust pipeline of wholly owned and partnered programmes to address a broad spectrum of disease indications.

Read more

Our focus

Our foundation is built on our proprietary soluble TCR bi-specific ImmTAC® platform.

Read more
Our clinical trials

Latest News

More News articles